Bayer Aktiengesellschaft (BAYN.DE)
51.84 EUR +3.64%
Bayer Aktiengesellschaft rose 3.64% in the latest session, at 51.84 EUR. By market cap it is number 2 of the 6 health care stocks on the DAX 40 heatmap. The price is 4.1% below its 52-week high.
Key numbers
- Price
- 51.84 EUR
- Day change
- +3.64% (1.82)
- Market cap
- 50.9B EUR
- P/E (trailing)
- —
- P/E (forward)
- 10.7
- Dividend yield
- 0.22%
- 50-day average
- 47.22
- 200-day average
- 43.53
- 52-week range
- 25.78 – 54.04
- Dividend per share (annual)
- 0.11 EUR
Data as of 3 Nov 2026, 17:39 CET. Market data may be delayed.
Bayer Aktiengesellschaft over the past year
From daily closing prices. The highest close in the period was 53.36 EUR on 2 Jul 2026, the lowest 26.06 EUR on 7 Nov 2025.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +11.30% | +6.15% | +33.74% | +35.15% | +88.97% |
| Month | Close (EUR) | Change |
|---|---|---|
| November 2026 | 50.02 | -1.11% |
| October 2026 | 50.58 | +5.48% |
| September 2026 | 47.95 | -2.22% |
| August 2026 | 49.04 | +2.06% |
| July 2026 | 48.05 | -0.74% |
| June 2026 | 48.41 | +32.52% |
| May 2026 | 36.53 | -3.99% |
| April 2026 | 38.05 | -3.39% |
| March 2026 | 39.38 | -6.25% |
| February 2026 | 42.01 | -5.72% |
| January 2026 | 44.56 | +20.40% |
| December 2025 | 37.01 | +21.40% |
Health care peers
Bayer Aktiengesellschaft is on the DAX 40 heatmap (Health care). How it compares with the other health care stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Merck KGaA MRK.DE | -0.57% | 64.8B EUR | 27.4 |
| Bayer Aktiengesellschaft BAYN.DE | +3.64% | 50.9B EUR | — |
| Siemens Healthineers AG SHL.DE | -0.12% | 48.5B EUR | 22.0 |
| Fresenius SE & Co. KGaA FRE.DE | +0.47% | 27.5B EUR | 17.6 |
| Fresenius Medical Care AG FME.DE | -3.60% | 10.5B EUR | 11.8 |
| Qiagen N.V. QIA.DE | +0.04% | 9.3B EUR | 26.6 |
More on BAYN
Open BAYN.DE in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.